Justin J.  File net worth and biography

Justin File Biography and Net Worth

Justin J. File serves as Chief Financial Officer of the Company. Mr. File has also served as the Chief Financial Officer of the women’s health nonprofit organization WCG Cares from November 2017 to May 2018. Mr. File has approximately 26 years of diverse accounting and finance experience within a variety of both public and private biotechnology and biopharmaceutical companies. Most recently, Mr. File provided executive financial and accounting oversight services to various biotechnology companies in San Diego, California, assisting in their initial public offering process and helping to establish and improve their accounting and finance operations as publicly-traded entities. Prior to this, Mr. File was Senior Director and Controller of Sequenom, Inc., a diagnostic company that developed and commercialized molecular diagnostics testing services for the women’s health market. During that time, Mr. File served as Treasurer of their diagnostic subsidiary and provided assistance in the raising of over $400 million in combined equity and convertible note offerings. Mr. File also assisted in the commercialization of four diagnostic tests in a two-year period, which included Sequenom’s revolutionary noninvasive prenatal test for Down syndrome. Earlier in his career Mr. File worked for approximately ten years in public accounting, primarily with Arthur Andersen LLP, where he worked with a variety of clients assisting with attestation and periodic reporting requirements, public offerings and acquisitions. Mr. File graduated from Central Washington University with a Bachelor of Science in Accounting and Business Administration and is a Certified Public Accountant (inactive).

What is Justin J. File's net worth?

The estimated net worth of Justin J. File is at least $34.88 as of June 10th, 2021. Mr. File owns 3,523 shares of Evofem Biosciences stock worth more than $35 as of November 22nd. This net worth approximation does not reflect any other investments that Mr. File may own. Learn More about Justin J. File's net worth.

How do I contact Justin J. File?

The corporate mailing address for Mr. File and other Evofem Biosciences executives is 12400 HIGH BLUFF DRIVE SUITE 600, SAN DIEGO CA, 92130. Evofem Biosciences can also be reached via phone at (858) 550-1900 and via email at [email protected]. Learn More on Justin J. File's contact information.

Has Justin J. File been buying or selling shares of Evofem Biosciences?

Justin J. File has not been actively trading shares of Evofem Biosciences over the course of the past ninety days. Most recently, on Monday, December 20th, Justin J. File bought 324 shares of Evofem Biosciences stock. The stock was acquired at an average cost of $46.25 per share, with a total value of $14,985.00. Learn More on Justin J. File's trading history.

Who are Evofem Biosciences' active insiders?

Evofem Biosciences' insider roster includes Russell Barrans (Insider), Justin File (CFO), Alexander Fitzpatrick (General Counsel), Kim Kamdar (Director), Anthony O'Brien (Director), Saundra Pelletier (CEO), and Lisa Rarick (Director). Learn More on Evofem Biosciences' active insiders.

Justin J. File Insider Trading History at Evofem Biosciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2021Buy324$46.25$14,985.00View SEC Filing Icon  
6/10/2021Buy196$128.75$25,235.003,523View SEC Filing Icon  
6/12/2020Buy68$392.50$26,690.00View SEC Filing Icon  
1/13/2020Sell13$750.00$9,750.001,418View SEC Filing Icon  
1/2/2020Sell26$756.25$19,662.501,431View SEC Filing Icon  
12/2/2019Sell80$895.00$71,600.001,458View SEC Filing Icon  
11/20/2019Sell0$750.00$0.001,658View SEC Filing Icon  
See Full Table

Justin J. File Buying and Selling Activity at Evofem Biosciences

This chart shows Justin J File's buying and selling at Evofem Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Evofem Biosciences Company Overview

Evofem Biosciences logo
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Read More

Today's Range

Now: $0.01
Low: $0.01
High: $0.01

50 Day Range

MA: $0.01
Low: $0.01
High: $0.01

2 Week Range

Now: $0.01
Low: $0.01
High: $0.23

Volume

308,508 shs

Average Volume

953,531 shs

Market Capitalization

$1.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A